Samsung Biologics Co Ltd
KRX:207940

Watchlist Manager
Samsung Biologics Co Ltd Logo
Samsung Biologics Co Ltd
KRX:207940
Watchlist
Price: 949 000 KRW 1.06% Market Closed
Market Cap: 67.5T KRW
Have any thoughts about
Samsung Biologics Co Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Samsung Biologics Co Ltd stock under the Base Case scenario is 490 861.55 KRW. Compared to the current market price of 949 000 KRW, Samsung Biologics Co Ltd is Overvalued by 48%.

Intrinsic Value
490 861.55 KRW
Overvaluation 48%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Samsung Biologics Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Samsung Biologics Co Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Samsung Biologics Co Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

949 000 KRW
+1.06%
+1.06%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Samsung Biologics Co Ltd
KR
Life Sciences Tools & Services
Market Cap
67.5T KRW
IPO
Nov 10, 2016
Employees
-
Korea
Market Cap
67.5T KRW
Industry
Life Sciences Tools & Services
IPO
Nov 10, 2016
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Samsung Biologics Co Ltd

Provide an overview of the primary business activities
of Samsung Biologics Co Ltd.

What unique competitive advantages
does Samsung Biologics Co Ltd hold over its rivals?

What risks and challenges
does Samsung Biologics Co Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Samsung Biologics Co Ltd.

Provide P/S
for Samsung Biologics Co Ltd.

Provide P/E
for Samsung Biologics Co Ltd.

Provide P/OCF
for Samsung Biologics Co Ltd.

Provide P/FCFE
for Samsung Biologics Co Ltd.

Provide P/B
for Samsung Biologics Co Ltd.

Provide EV/S
for Samsung Biologics Co Ltd.

Provide EV/GP
for Samsung Biologics Co Ltd.

Provide EV/EBITDA
for Samsung Biologics Co Ltd.

Provide EV/EBIT
for Samsung Biologics Co Ltd.

Provide EV/OCF
for Samsung Biologics Co Ltd.

Provide EV/FCFF
for Samsung Biologics Co Ltd.

Provide EV/IC
for Samsung Biologics Co Ltd.

Show me price targets
for Samsung Biologics Co Ltd made by professional analysts.

What are the Revenue projections
for Samsung Biologics Co Ltd?

How accurate were the past Revenue estimates
for Samsung Biologics Co Ltd?

What are the Net Income projections
for Samsung Biologics Co Ltd?

How accurate were the past Net Income estimates
for Samsung Biologics Co Ltd?

What are the EPS projections
for Samsung Biologics Co Ltd?

How accurate were the past EPS estimates
for Samsung Biologics Co Ltd?

What are the EBIT projections
for Samsung Biologics Co Ltd?

How accurate were the past EBIT estimates
for Samsung Biologics Co Ltd?

Compare the revenue forecasts
for Samsung Biologics Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Samsung Biologics Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Samsung Biologics Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Samsung Biologics Co Ltd compared to its peers.

Compare the P/E ratios
of Samsung Biologics Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Samsung Biologics Co Ltd with its peers.

Analyze the financial leverage
of Samsung Biologics Co Ltd compared to its main competitors.

Show all profitability ratios
for Samsung Biologics Co Ltd.

Provide ROE
for Samsung Biologics Co Ltd.

Provide ROA
for Samsung Biologics Co Ltd.

Provide ROIC
for Samsung Biologics Co Ltd.

Provide ROCE
for Samsung Biologics Co Ltd.

Provide Gross Margin
for Samsung Biologics Co Ltd.

Provide Operating Margin
for Samsung Biologics Co Ltd.

Provide Net Margin
for Samsung Biologics Co Ltd.

Provide FCF Margin
for Samsung Biologics Co Ltd.

Show all solvency ratios
for Samsung Biologics Co Ltd.

Provide D/E Ratio
for Samsung Biologics Co Ltd.

Provide D/A Ratio
for Samsung Biologics Co Ltd.

Provide Interest Coverage Ratio
for Samsung Biologics Co Ltd.

Provide Altman Z-Score Ratio
for Samsung Biologics Co Ltd.

Provide Quick Ratio
for Samsung Biologics Co Ltd.

Provide Current Ratio
for Samsung Biologics Co Ltd.

Provide Cash Ratio
for Samsung Biologics Co Ltd.

What is the historical Revenue growth
over the last 5 years for Samsung Biologics Co Ltd?

What is the historical Net Income growth
over the last 5 years for Samsung Biologics Co Ltd?

What is the current Free Cash Flow
of Samsung Biologics Co Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Samsung Biologics Co Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Samsung Biologics Co Ltd

Current Assets 4.8T
Cash & Short-Term Investments 946.8B
Receivables 1.1T
Other Current Assets 2.8T
Non-Current Assets 11.2T
Long-Term Investments 53B
PP&E 5.1T
Intangibles 5.7T
Other Non-Current Assets 334.3B
Current Liabilities 3.6T
Accounts Payable 191.2B
Accrued Liabilities 338.5B
Short-Term Debt 377B
Other Current Liabilities 2.7T
Non-Current Liabilities 1.9T
Long-Term Debt 224.4B
Other Non-Current Liabilities 1.6T
Efficiency

Earnings Waterfall
Samsung Biologics Co Ltd

Revenue
4.4T KRW
Cost of Revenue
-2.2T KRW
Gross Profit
2.2T KRW
Operating Expenses
-809B KRW
Operating Income
1.3T KRW
Other Expenses
-291.9B KRW
Net Income
1.1T KRW

Free Cash Flow Analysis
Samsung Biologics Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Samsung Biologics Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Years Revenue Growth
Positive Gross Profit
Positive Operating Income
Positive Net Income
62/100
Profitability
Score

Samsung Biologics Co Ltd's profitability score is 62/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Samsung Biologics Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
86/100
Solvency
Score

Samsung Biologics Co Ltd's solvency score is 86/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Samsung Biologics Co Ltd

Wall Street analysts forecast Samsung Biologics Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Samsung Biologics Co Ltd is 1 252 101 KRW with a low forecast of 848 400 KRW and a high forecast of 1 470 000 KRW.

Lowest
Price Target
848 400 KRW
11% Downside
Average
Price Target
1 252 101 KRW
32% Upside
Highest
Price Target
1 470 000 KRW
55% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Samsung Biologics Co Ltd?

Click here to dive deeper.

Dividends

Samsung Biologics Co Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for Samsung Biologics Co Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Samsung Biologics Co Ltd stock?

The intrinsic value of one Samsung Biologics Co Ltd stock under the Base Case scenario is 490 861.55 KRW.

Is Samsung Biologics Co Ltd stock undervalued or overvalued?

Compared to the current market price of 949 000 KRW, Samsung Biologics Co Ltd is Overvalued by 48%.

Back to Top